Survey on barriers to psychiatrists’ use of clozapine for young people in Scotland and suggestions for reducing these
PLOS ONE · 20.06.2024 · 19 (6) · e0304996
DOI: 10.1371/journal.pone.0304996 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.06.2024. Verfasst von Graham Walker und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Glasgow, Glasgow, United Kingdom. Hauptthemen laut MEDLINE: Clozapine, Psychiatry, Antipsychotic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The Mental Welfare Commission for Scotland published a report into the death of a young person, with recommendations for the Royal College of Psychiatry in Scotland Child and Adolescent Faculty; to explore if there were barriers to the use of Clozapine in young people in Scotland.
Methods
A mixed-methods study was performed using a cross-sectional survey of clinicians working in child and adolescent psychiatry across Scotland, to determine attitudes towards clozapine use and the perceived barriers and facilitators to clozapine treatment.
Results
Results suggest that there may be a lack of clearly defined pathways within and between services, as well as a lack of resources provided for the necessary monitoring of a young person started on clozapine. Multiple respondents felt unskilled in clozapine initiation and had not accessed formal training. The most frequently mentioned themes for improving facilitation of clozapine prescription were that of increased resources and training.
Discussion
National policymakers including the Mental Welfare Commission, NHS Education for Scotland, and NHS Scotland should consider these findings to address the potential underutilisation of clozapine for people aged under 18 in services across Scotland. A review of current service provision should take place, with consideration of whether the facilitators to clozapine prescription which our study has highlighted could be implemented more effectively. This may help reduce identified barriers and increase clozapine prescription to those who would benefit from it, potentially improving outcomes for young people with treatment-resistant psychosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Glasgow, Glasgow, United Kingdom.
- NHS Scotland, United Kingdom.
ORCID-Profile: Graham Walker
Zitieren
APA
Walker, G., Lang, J., & Smith, H. (2024). Survey on barriers to psychiatrists’ use of clozapine for young people in Scotland and suggestions for reducing these. PLOS ONE, 19(6), e0304996. https://doi.org/10.1371/journal.pone.0304996
Vancouver
Walker G, Lang J, Smith H. Survey on barriers to psychiatrists’ use of clozapine for young people in Scotland and suggestions for reducing these. PLOS ONE. 2024;19(6):e0304996. doi:10.1371/journal.pone.0304996
BibTeX
@article{Walker2024,
author = {Walker, Graham and Lang, Jason and Smith, Helen},
title = {Survey on barriers to psychiatrists’ use of clozapine for young people in Scotland and suggestions for reducing these},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {6},
pages = {e0304996},
doi = {10.1371/journal.pone.0304996}
}
EUVIMED